NewsNew Australian patent approval for Episurf Medical

The Australian patent office IP Australia has announced that Episurf Medical (NASDAQ: EPIS B) has obtained another granted patent in Australia.

The patent, entitled “Surgical kit for cartilage repair comprising implant and a set of tools, has a focus on the company’s individualised Episealer® Femoral Twin implant and its design.

“The Episealer® twin technology is an appreciated solution for the commonly occurring elongated cartilage lesions, and we thus welcome this first approval of this patent family”, comments Pål Ryfors, CEO, Episurf Medical.

For more  information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com